News & Insights



Banks and businesses were all rushing to comply with the EU General Data Protection Regulation (GDPR), which came into effect on 25 May 2018. While data protection regulation is not a new concept in the EU, the GDPR significantly expands the rules on using personal data and increases the risks of processing personal data compared to existing legislation. Even deal parties with little or no footprint in the EU may be affected. Failing to comply with the new rules can have serious reputational and financial consequences for a business, including fines for data breaches of up to the maximum of either Euro 20 million or 4% of global turnover.

The global frenzy around cryptocurrencies has seen prices fluctuate dramatically over the past year, leading to a growing interest among Malaysian investors. The Central Bank of Malaysia (BNM) has repeatedly maintained its position that digital currencies are not legal tender in Malaysia, and has advised the public to be cautious of the risks that come with them.

Baker McKenzie’s analysis of 2016 healthcare IPOs shows a record year for biotech led to a 2% increase in capital raised from healthcare IPOs in 2016 despite a 39% decline in the volume of listings. Biotech deals, which include healthtech listings, continue to dominate the sector in terms of value, accounting for 45% of total capital raised with USD 8.16 billion from 27 deals. “While healthcare IPOs volume slowed in 2016, the sector outperformed in…

Posted by Sue Wan Wong of Wong & Partners (member firm of Baker & McKenzie International) In February 2015, the Malaysian Securities Commission (SC) issued the Guidelines on Regulation of Markets under Section 34 of the Capital Markets and Services Act (CMSA) setting out the framework for the regulation of equity crowdfunding (ECF). Please click here for our client alert released earlier this year, which summarizes these guidelines and the equity crowdfunding framework in Malaysia. In April…